Research Article
Volume 4 Issue 12 - 2020
A Systematic Scoping Review of Cancer Patients’ Treatment during the COVID-19 Pandemic
Shafi U Bhuiyan1,2*, Housne Begum2,3, Afsheen Rizwan2, Amandeep Thakur2, Ammar Al-Douri2, Christine Arquero2, Edith Quintanilla2 and Muhammed Awlad Hussain2
1University of Toronto, Toronto, ON, Canada
2Ryerson University, Toronto, ON, Canada
3McMaster University, Hamilton, ON, Canada
*Corresponding Author: Shafi U Bhuiyan, University of Toronto and Ryerson University, Toronto, ON, Canada.
Received: October 14, 2020; Published: November 25, 2020


Amongst the global effects of coronavirus disease (COVID-19), one of the challenges faced by health practitioners is how to continue offering treatment to cancer patients. This crisis has led to the collaboration of medical experts to discuss new strategies in the wake of this pandemic. Oncology treatment guidelines have been modified around the world to ensure the safety of this immunocompromised population by reducing exposure to coronavirus through different isolation and teleconsultation measures while providing life-saving treatments in these unprecedented settings. This scoping review summarizes the changes in the treatment of cancer patients as mentioned in the most up-to-date literature available through the first half of the year 2020. It is composed of narrative reviews, discussion or opinion papers, and reviews of current treatment guidelines for multiple types of cancers, including the extra measures needed to avoid infection. This paper aims to provide evidence-based decisions on how to deliver treatment effectively without compromising cancer patients’ safety.

Keywords:COVID-19; SARS-CoV-2; Cancer Treatment; Pandemic


  1. WHO Director-General’s opening remarks at the media briefing on COVID-19 (2020).
  2. Coronavirus disease (COVID-19) – World Health Organization (2019).
  3. Wu Y-C., et al. “The outbreak of COVID-19: An overview”. Journal of the Chinese Medical Association 3 (2020): 217-220.
  4. Addeo A and Friedlaender A. “Cancer and COVID-19: Unmasking their ties”. Cancer Treatment Reviews 88 (2020): 102041.
  5. Marcum M., et al. “COVID-19 pandemic and impact on cancer clinical trials: An academic medical center perspective”. Cancer Medicine 17 (2020): 6141-6146.
  6. Tian J., et al. “Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study”. The Lancet Oncology 7 (2020): 893-903.
  7. Salako O., et al. “Upheaval in cancer care during the COVID-19 outbreak”. Ecancer Medical Science 14 (2020): ed97.
  8. Saini KS., et al. “Effect of the COVID-19 pandemic on cancer treatment and research”. The Lancet Haematology 6 (2020): e432-e435.
  9. Yu J., et al. “SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China”. JAMA Oncology (2020).
  10. Baldotto C., et al. “Lung Cancer and the COVID-19 pandemic: Recommendations from the Brazilian Thoracic Oncology Group”. Clinics 75 (2020): e2060.
  11. Patel RJ., et al. “Early institutional head and neck oncologic and microvascular surgery practice patterns across the United States during the SARS-CoV-2 (COVID19) pandemic”. Head Neck 6 (2020): 1168-1172.
  12. Barry A., et al. “Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective”. The Lancet Gastroenterology and Hepatology 8 (2020): 765-775.
  13. Dingemans A-MC., et al. “Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic”. International Association for the Study of Lung Cancer 7 (2020): 1119-1136.
  14. Han AY., et al. “Time for a Paradigm Shift in Head and Neck Cancer Management During the COVID-19 Pandemic”. Otolaryngology-Head and Neck Surgery Off J American Academy of Otolaryngology-Head and Neck Surgery 3 (2020): 447-454.
  15. Turri-Zanoni M., et al. “Managing care for patients with sinonasal and anterior skull base cancers during the COVID-19 pandemic”. Head Neck7 (2020): 1503-1506.
  16. Ueda M., et al. “Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal”. Journal of the National Comprehensive Cancer Network 4 (2020): 366-369.
  17. Uwins C., et al. “COVID-19 and gynecological cancer: a review of the published guidelines”. The International Journal of Gynecological Cancer (2020).
  18. Singh AP., et al. “Management of Lung Cancer During the COVID-19 Pandemic”. JCO Oncology Practice (2020): OP2000286.
  19. Vordermark D. “Shift in indications for radiotherapy during the COVID-19 pandemic? A review of organ-specific cancer management recommendations from multidisciplinary and surgical expert groups”. Radiation Oncology Journal 1 (2020): 140.
  20. Saverio SD., et al. “Coronavirus pandemic and colorectal surgery: practical advice based on the Italian experience”. Colorectal Disease 6 (2020): 625-634.
  21. Zhao Z., et al. “Recommendations of individualized medical treatment and common adverse events management for lung cancer patients during the outbreak of COVID-19 epidemic”. Thorac Cancer6 (2020): 1752-1757.
  22. Mistretta FA., et al. “A Guide for Oncologic Patient Management during Covid-19 Pandemic: The Initial Experience of an Italian Oncologic Hub with Exemplificative Focus on Uro-Oncologic Patients”. Cancers6 (2020).
  23. Sheng JY., et al. “Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific Approach”. JCO Oncology Practice (2020): OP2000364.
  24. Williams VM., et al. “COVID-19 impact on timing of brachytherapy treatment and strategies for risk mitigation”. Brachytherapy4 (2020): 401-411.
  25. Maio M., et al. “Immune Checkpoint Inhibitors for Cancer Therapy in the COVID-19 Era”. Clinical Cancer Research 16 (2020): 4201-4205.
  26. Nguyen NP., et al. “Older Cancer Patients during the COVID-19 Epidemic: Practice Proposal of the International Geriatric Radiotherapy Group”. Cancers5 (2020).
  27. Vidya R., et al. “Should breast reconstruction and breast oncoplastic procedures be performed during the coronavirus pandemic? (2020).
  28. Sternberg C., et al. “Oncology practice during COVID-19 pandemic: a fast response is the best response”. Revista da Associação Médica Brasileira 3 (2020): 338-344.
  29. Marti C and Sánchez-Méndez JI. “Neoadjuvant endocrine therapy for luminal breast cancer treatment: a first-choice alternative in times of crisis, such as the COVID-19 pandemic (2020).
  30. Mirnezami R., et al. “Preoperative radiotherapy for locally advanced rectal cancer during and after the COVID-19 pandemic”. British Journal of Surgery 8 (2020): e263-e263.
  31. Marijnen CAM., et al. “International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic”. Journal of the European Society for Radiotherapy and Oncology 148 (2020): 213-215.
  32. Skowron KB., et al. “Caring for Patients with Rectal Cancer During the COVID-19 Pandemic”. The Journal of Gastrointestinal Surgery Off J Society for Surgery of the Alimentary Tract 7 (2020): 1698-1703.
  33. Alshamrani M., et al. “Practical strategies to manage cancer patients during the COVID-19 pandemic: Saudi Oncology Pharmacy Assembly Experts recommendations”. Journal of Oncology Pharmacy Practice Off Publ Inter Social Oncology Pharm Pract 6 (2020): 1429-1440.
  34. Specht M., et al. “High-Efficiency Same-Day Approach to Breast Reconstruction During the COVID-19 Crisis”. Breast Cancer Research and Treatment 3 (2020): 679-688.
  35. Omarini C., et al. “Cancer treatment during the coronavirus disease 2019 pandemic: Do not postpone, do it!”. The European Journal of Cancer 133 (2020): 29-32.
  36. Indini A., et al. “Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: a nationwide Italian survey”. European Journal of Cancer 132 (2020): 17-23.
  37. De Joode K., et al. “Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients’ perspective”. European Journal of Cancer 136 (2020): 132-139.
  38. Liang W., et al. “Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China”. The Lancet Oncology 3 (2020): 335-337.
  39. Dai M., et al. “Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak”. Cancer Discovery 6 (2020): 783-791.
  40. Xia Y., et al. “Risk of COVID-19 for patients with cancer”. The Lancet Oncology 4 (2020): e180.
Citation: Shafi U Bhuiyan.,et al. “A Systematic Scoping Review of Cancer Patients’ Treatment during the COVID‐19 Pandemic”. EC Emergency Medicine and Critical Care 4.12 (2020): 34-44.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

March Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the March issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before April 14, 2023.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.